Actionable news
All posts from Actionable news
Actionable news in IMGN: ImmunoGen, Inc.,

Trade-Ideas: Immunogen (IMGN) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Immunogen ( IMGN) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Immunogen as such a stock due to the following factors:

  • IMGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $12.7 million.
  • IMGN has traded 54,092 shares today.
  • IMGN is up 4.7% today.
  • IMGN was down 5.2% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in IMGN with the Ticky from Trade-Ideas. See the FREE profile for IMGN NOW at Trade-Ideas More details on IMGN: ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugates technology. It offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. Currently there are 4 analysts that rate Immunogen a buy, 1 analyst rates it a sell, and 4 rate it a hold. The average volume for Immunogen has been 1.3 million shares per day over the past 30 days. Immunogen has a market cap of $942.8 million and is part of the...